| Literature DB >> 35419551 |
Chongyuan Luo1,2,3,4, Hanqing Liu1,5,4, Fangming Xie6,7,4, Ethan J Armand7, Kimberly Siletti8, Trygve E Bakken9, Rongxin Fang10,11, Wayne I Doyle7, Tim Stuart12, Rebecca D Hodge9, Lijuan Hu8, Bang-An Wang1, Zhuzhu Zhang1, Sebastian Preissl11,13, Dong-Sung Lee14, Jingtian Zhou1, Sheng-Yong Niu1, Rosa Castanon1, Anna Bartlett1, Angeline Rivkin1, Xinxin Wang10,11, Jacinta Lucero15, Joseph R Nery1, David A Davis16, Deborah C Mash16,17, Rahul Satija12,17, Jesse R Dixon14,17, Sten Linnarsson8,17, Ed Lein9,17, M Margarita Behrens15,17, Bing Ren10,11,17, Eran A Mukamel7,17, Joseph R Ecker1,2,17,18.
Abstract
Single-cell technologies measure unique cellular signatures but are typically limited to a single modality. Computational approaches allow the fusion of diverse single-cell data types, but their efficacy is difficult to validate in the absence of authentic multi-omic measurements. To comprehensively assess the molecular phenotypes of single cells, we devised single-nucleus methylcytosine, chromatin accessibility, and transcriptome sequencing (snmCAT-seq) and applied it to postmortem human frontal cortex tissue. We developed a cross-validation approach using multi-modal information to validate fine-grained cell types and assessed the effectiveness of computational data fusion methods. Correlation analysis in individual cells revealed distinct relations between methylation and gene expression. Our integrative approach enabled joint analyses of the methylome, transcriptome, chromatin accessibility, and conformation for 63 human cortical cell types. We reconstructed regulatory lineages for cortical cell populations and found specific enrichment of genetic risk for neuropsychiatric traits, enabling the prediction of cell types that are associated with diseases.Entities:
Year: 2022 PMID: 35419551 PMCID: PMC9004682 DOI: 10.1016/j.xgen.2022.100107
Source DB: PubMed Journal: Cell Genom ISSN: 2666-979X